BlackRock, Inc. 13D and 13G filings for ANI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 4:13 pm Purchase |
2023-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
2,524,660 12.400% |
541,423 (+27.30%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,983,237 11.400% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,983,237 11.400% |
296,624 (+17.59%) |
Filing |
| 2022-02-07 4:41 pm Purchase |
2021-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,686,613 11.800% |
97,385 (+6.13%) |
Filing |
| 2021-01-26 6:52 pm Purchase |
2020-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,589,228 12.900% |
41,479 (+2.68%) |
Filing |